PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹265 Cr | ₹271 Cr | ₹85 Cr | ₹960 Cr | ₹741 Cr |
What is the latest Total Non-Current Liabilities ratio of PANACEA BIOTEC ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹265 Cr |
Mar2023 | ₹271 Cr |
Mar2022 | ₹85 Cr |
Mar2021 | ₹960 Cr |
Mar2020 | ₹741 Cr |
How is Total Non-Current Liabilities of PANACEA BIOTEC Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹265 Cr | -2.07 | |
Mar2023 | ₹271 Cr | 218.11 | |
Mar2022 | ₹85 Cr | -91.14 | |
Mar2021 | ₹960 Cr | 29.61 | |
Mar2020 | ₹741 Cr | - |
Compare Total Non-Current Liabilities of peers of PANACEA BIOTEC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PANACEA BIOTEC | ₹2,090.9 Cr | -1.1% | -20.6% | 98.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,228.0 Cr | -2.4% | -7.2% | 27.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹148,023.0 Cr | 0% | -9.2% | 61.5% | Stock Analytics | |
CIPLA | ₹119,474.0 Cr | 6% | -3.8% | 10.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,599.0 Cr | 1.7% | -11.4% | 2.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,604.7 Cr | 5.2% | -2.1% | 26.1% | Stock Analytics |
PANACEA BIOTEC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PANACEA BIOTEC | -1.1% |
-20.6% |
98.5% |
SENSEX | 1.7% |
-1.3% |
7.7% |
You may also like the below Video Courses